- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Incorporated in 1993, Omkar Specialty Chemicals Ltd is engaged in the manufacture and sale of Specialty Chemicals and Pharma Intermediates for Chemical and Allied Industries.
The company clarified exchange queries on its FY26 audited financial results, submitting a revised, more legible version with an unmodified audit opinion. The financial figures remain unchanged. These results reflect the approved resolution plan, including a ₹226.65 Cr resolution amount and significant asset/liability restatement, upholding the going concern view.
Omkar Speciality Chemicals announced a board meeting on June 12, 2026, approving standalone audited financial results for FY26, with a net loss of ₹1.59 Cr. A Nomination & Remuneration Committee was formed, and the registered office address changed. The company is in revival mode post-Resolution Plan approval, despite suspended operations.